ImmuPharma (LSE:IMM) Total Tax Payable : £0.00 Mil (As of Jun. 2023)

View and export this data going back to 2003. Start your Free Trial

What is ImmuPharma Total Tax Payable?

ImmuPharma's Total Tax Payable for the quarter that ended in Jun. 2023 was £0.00 Mil.

ImmuPharma's quarterly Total Tax Payable increased from Jun. 2022 (£0.00 Mil) to Dec. 2022 (£0.18 Mil) but then declined from Dec. 2022 (£0.18 Mil) to Jun. 2023 (£0.00 Mil).

ImmuPharma's annual Total Tax Payable increased from Dec. 2020 (£0.09 Mil) to Dec. 2021 (£0.27 Mil) but then declined from Dec. 2021 (£0.27 Mil) to Dec. 2022 (£0.18 Mil).

ImmuPharma Total Tax Payable Historical Data

The historical data trend for ImmuPharma's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuPharma Total Tax Payable Chart

ImmuPharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Tax Payable

Get a 7-Day Free Trial

0.11

0.07

0.09

0.27

0.18

ImmuPharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Tax Payable	Get a 7-Day Free Trial															-	0.27	-	0.18	-

ImmuPharma Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

ImmuPharma Total Tax Payable Related Terms

Thank you for viewing the detailed overview of ImmuPharma's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuPharma (LSE:IMM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

IMM.GB:UK 25I:Germany

Address

One Bartholomew Close, London, GBR, EC1A 7BL

Website

https://www.immupharma.co.uk

ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus and a life-threatening autoimmune disease.

ImmuPharma (LSE:IMM) Headlines

No Headlines